Related Experiment Videos

Alternative splicing of MLH1 messenger RNA in human normal cells

F Charbonnier1, C Martin, M Scotte

  • 1Laboratoire de Génétique Moléculaire, Centre Hospitalo-Universitaire de Rouen, France.

Cancer Research
|May 1, 1995
PubMed

Insights

Researchers found three new forms of hMLH1 mRNA in normal cells. These alternative splicing variants may lead to truncated hMLH1 proteins, impacting DNA mismatch repair and cancer risk.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • The hMLH1 protein is crucial for DNA mismatch repair and is homologous to bacterial MutL.
  • Germline mutations in the hMLH1 gene are linked to hereditary nonpolyposis colorectal cancer.
  • Understanding hMLH1's function is vital for cancer genetics.

Purpose of the Study:

  • To investigate alternative splicing of hMLH1 mRNA in normal human tissues.
  • To identify and characterize different hMLH1 mRNA transcripts.
  • To explore potential implications for protein function and hereditary cancer.

Main Methods:

  • Analysis of mRNA from normal lymphocytes and tissues.
  • Identification and sequencing of alternatively spliced hMLH1 transcripts.
  • Prediction of protein products from identified transcripts.

Main Results:

  • Three alternatively spliced forms of hMLH1 mRNA were detected.
  • One variant lacks codons 227-295.
  • Two variants predict truncated proteins with 264 and 226 N-terminal amino acids.

Conclusions:

  • Alternative splicing of hMLH1 mRNA occurs in normal human cells.
  • These splice variants may produce non-functional or altered hMLH1 proteins.
  • The biological significance of hMLH1 alternative splicing requires further investigation.

Related Concept Videos